Provention bio, inc. (PRVB)
Balance Sheet / Yearly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Dec'17
ASSETS
Current assets:
Cash and cash equivalents

37,142

39,165

95,088

41,259

51,206

58,539

64,297

10,209

21,834

Marketable securities

39,487

46,208

-

-

-

-

-

-

-

Prepaid expenses and other current assets

1,488

623

1,283

1,187

698

2,990

2,025

2,027

594

Total assets

78,117

85,996

96,371

42,446

51,904

61,529

66,322

12,236

22,428

LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable

3,536

1,775

2,265

3,801

779

568

524

887

459

Accrued expenses

3,367

2,065

2,695

1,237

2,195

1,303

710

806

819

Total current liabilities

6,903

3,840

4,960

5,038

2,974

1,871

1,234

1,693

1,278

Warrant liability

-

-

-

-

-

-

0

1,301

998

Total liabilities

-

-

-

-

-

-

1,234

2,994

2,276

Commitments and Contingencies (Note 6)

-

-

-

-

-

-

0

0

-

Series A Convertible Redeemable Preferred Stock, $0.0001 Par Value: Series A Convertible Redeemable Preferred Stock, no shares authorized, issued or outstanding at December 31, 2018; 13,000,000 shares authorized, 11,381,999 shares issued and outstanding at December 31, 2017; Liquidation preference of $28,455 at December 31, 2017

-

-

-

-

-

-

0

26,436

26,185

Stockholders' equity:
Preferred stock, $0.0001 par value; 25,000,000 shares authorized; no shares issued or outstanding at March 31, 2020 and December 31, 2019

-

-

-

-

-

-

0

-

-

Common stock, $0.0001 par value; 100,000,000 shares authorized; 47,712,636 issued and outstanding at March 31, 2020; 47,658,361 share issued and oustanding at December 31, 2019

5

5

5

4

4

4

4

1

1

Additional paid-in capital

162,642

161,212

159,927

96,156

95,674

95,430

95,176

7,505

3,264

Accumulated other comprehensive income

210

-

-

-

-

-

-

-

-

Accumulated deficit

-91,643

-79,061

-68,521

-58,752

-46,748

-35,776

-30,092

-24,700

-9,298

Total stockholders' equity

71,214

82,156

91,411

37,408

48,930

59,658

65,088

-17,194

-6,033

Total liabilities, preferred stock and stockholders' equity

78,117

85,996

96,371

42,446

51,904

61,529

66,322

12,236

22,428